Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP3 pseudogene 1 (THAP3P1) is classified as a processed pseudogene related to the protein-coding THAP3 gene, which encodes a transcriptional regulator involved in processes such as transcription regulation and neuronal development. As a pseudogene, THAP3P1 is generally considered non-functional for protein-coding, lacking the ability to produce a functional protein due to disabling mutations, lack of promoter sequences, or integration into non-coding regions of the genome. Like other pseudogenes, it may have potential regulatory roles in gene expression (for example, through microRNA sponging or competing endogenous RNA (ceRNA) mechanisms) but no specific biological or clinical functions have been definitively established for THAP3P1 in the scientific literature. It is not considered a direct therapeutic target and is typically excluded from drug development pipelines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain containing 3 pseudogene 1 (THAP3P1).